Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-19-054880

Chairman and CEO bought 16,500 shares at $2.98 ($49,170)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2019-11-01 Purchase +16,500 $2.98 $49,170 10,287,893 D
Open-market purchases · 16,500 sh · avg $2.98 · $49,170
Loading xslF345X03/doc4.xml…